ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2012

Abstract Number: 443

Secreted Frizzled-Related Protein 5 Exerts the Anti-Inflammatory Role in Rheumatoid Arthritis Via Down-Regulation of c-Jun N-Terminal Kinase

Yong-Jin Kwon1, Tae-Yeon Kim2, Sang-Won Lee3, Yong-Beom Park3, Soo Kon Lee4 and Min-Chan Park1, 1Department of Internal Medicine, Yonse University College of Medicine, Seoul, South Korea, 2Dept. of Internal Medicine, Yonse University College of Medicine, Seoul, South Korea, 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, 4Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: Adipocytokines and rheumatoid arthritis (RA)

Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenisis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Secreted frizzled-related protein 5 (Sfrp5) is a novel adipokine that has beneficial effects on metabolic dysfunction by controlling inflammatory cells within adipose tissue. Sfrp5 acts as a soluble modulator that binds and sequesters Wnt proteins in the extracellular space and that prevents the activation of frizzled and attenuating non-canonical Wnt signaling. Consequentially, c-Jun N-terminal kinase (JNK), a downstream target of non-canonical Wnt signaling, is inhibited. The purposes of this study are to determine the expression of Sfrp5 in fibroblast-like synoviocyte (FLS) from rheumatoid arthritis (RA) patients and to investigate the correlation between the expression levels of Sfrp5 and that of pro-inflammatory genes in RA FLS.  

Methods:

FLS were isolated and cultured from synovial tissues obtained from patients with RA or osteoarthritis (OA) during total knee replacement surgery. The mRNA expressions of Sfrp5 in peripheral blood mononuclear cells (PBMCs) and FLS from patients with RA or OA were determined using real-time quantitative RT-PCR. Adenovirus containing Sfrp5 transcript was constructed and delivered into RA FLS to strengthen Sfrp5 expression, then, Sfrp5 RNAi plasmid was transfected to abrogate Sfrp5 expression in RA FLS. The mRNA expressions of TNF-α, IL-1β, IL-6, CCL-2, CCL-7, COX-2 and MMP-9 were also determined using quantitative real-time PCR and western blot analysis was performed to assess MKK4, MKK-7, ATF-2, c-Jun and JNK activity in RA FLS.

Results:

Expression of Sfrp5 mRNA in PMBCs from RA patients was significantly decreased compared to those from OA patients, and this decrease was more accentuated in RA FLS compared to OA FLS (more than 10-fold in OA FLS). The mRNA expressions of TNF-α, IL-1β, IL-6, CCL-2, CCL-7, COX-2 and MMP-9 were remarkably increased in Sfrp5 RNAi plasmid-transfected RA FLS, compared to non-silencing RNAi plasmid-transfected RA FLS. However, adenoviral vectors encoding Sfrp5 significantly reduced the mRNA levels of TNF-α, IL-1β, IL-6, CCL-2, CCL-7, COX-2 and MMP-9 as compared with control vector. The activity of MKK4, MKK-7, ATF-2, c-Jun and JNK were up-regulated in RA FLS with no Sfrp5 expression by Sfrp5 RNAi plasmid; and were down-regulated with strong Sfrp5 expression by adenoviral vectors encoding Sfrp5.

Conclusion:

Sfrp5 suppressed various pro-inflammatory gene expressions via modulation of JNK. These findings suggest that Sfrp5 may have a certain role in RA pathogenesis and have an anti-inflammatory effect.


Disclosure:

Y. J. Kwon,
None;

T. Y. Kim,
None;

S. W. Lee,
None;

Y. B. Park,
None;

S. K. Lee,
None;

M. C. Park,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/secreted-frizzled-related-protein-5-exerts-the-anti-inflammatory-role-in-rheumatoid-arthritis-via-down-regulation-of-c-jun-n-terminal-kinase/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology